Session » Patient Outcomes, Preferences, and Attitudes Poster I

Date: Sunday, November 5, 2017

Time: 9:00AM-11:00AM

Meeting: 2017 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 340

Accessing Positive (but Not Negative) Online Reviews Is Associated with Increased Willingness to Take Medication

9:00AM-11:00AM: Abstract Number: 357

Determinants of Patient and Physician Disagreement on Presence of a Gout Flare

9:00AM-11:00AM: Abstract Number: 347

Disease Burden at One Academic Rheumatology Routine Care Setting Is Similar in Osteoarthritis (OA) and Rheumatoid Arthritis (RA) at First Visit but Significantly Greater in OA at a 6-Month Follow-up Visit

9:00AM-11:00AM: Abstract Number: 360

Evaluation of the Educational Needs in Argentinian Patients with Rheumatoid Arthritis Using the SpENAT Questionnaire

9:00AM-11:00AM: Abstract Number: 342

Health Related Quality of Life Is Comparable in Psoriatic Arthritis and Rheumatoid Arthritis Patients in Spite of Different Disease Activity. SF-36 Data from a Large Prospective Observational Multicentre Study

9:00AM-11:00AM: Abstract Number: 351

Integration of Electronically Captured Patient-Reported Outcomes in a Pediatric Rheumatology Clinic Visit

9:00AM-11:00AM: Abstract Number: 338

Measurement Properties of Paindetect, a Neuropathic Pain Screening Tool, for Evaluating Pain Phenotype in Patients with Rheumatoid Arthritis: Developing Neuropathic Pain Scale As a Measure of Treatment Outcome By Applying Rasch Analysis

9:00AM-11:00AM: Abstract Number: 361

Multi-National Observational Patient Diary Study to Assess Disease Burden of Periodic Fever Syndromes (PFS), Including Colchicine-Resistant Familial Mediterranean Fever (crFMF), TNF-Receptor Associated Periodic Syndrome (TRAPS) and Mevalonate Kinase Deficiency (MKD)

9:00AM-11:00AM: Abstract Number: 354

Multidomain Functional Assessment in a Cohort of Patients with Systemic Lupus Erythematosus: A Pilot Study

9:00AM-11:00AM: Abstract Number: 359

Nurse Telephone Education for Promoting a Treat-to-Target Approach in Recently Diagnosed Rheumatoid Arthritis Patients – a Preliminary Review

9:00AM-11:00AM: Abstract Number: 353

Patient Experiences of Rheumatoid Arthritis Models of Care: An International Survey

9:00AM-11:00AM: Abstract Number: 337

Patient-Reported Flares Were Correctly Predicted By an Algorithm Using Machine-Learning Statistics on Activity Tracker Data on Steps, in a Longitudinal 3-Month Study of 170 Patients with Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (axSpA)

9:00AM-11:00AM: Abstract Number: 336

Patient–Reported Barriers to Achieving Rheumatoid Arthritis Disease Control

9:00AM-11:00AM: Abstract Number: 358

Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 350

Patients with Gout Consider Zero Flares over the Previous Six or Twelve Months Necessary for a Remission State

9:00AM-11:00AM: Abstract Number: 339

Patients’ Attitudes and Experiences of Transitional Care in Paediatric Rheumatology: A Systematic Review of Qualitative Studies

9:00AM-11:00AM: Abstract Number: 362

Patients’ Experiences and Attitudes about Non-Medical Switching of Biologics: Results from an Online Patient Survey

9:00AM-11:00AM: Abstract Number: 355

Perceptions and Outcomes of Pregnancy and Lactation in Patients with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 349

Preferences and Satisfaction in a Pediatric Multidisciplinary Infusion Center

9:00AM-11:00AM: Abstract Number: 356

Preliminary Real World Data on Switching Patterns between Etanercept, Its Recently Marketed Biosimilar Counterpart and Its Competitor Adalimumab, Using Swedish Prescription Registry

9:00AM-11:00AM: Abstract Number: 335

Psoriatic Arthritis Patients Who Attain a Very Low Disease Activity State Have a Minimal Impact of the Disease on Their Lives

9:00AM-11:00AM: Abstract Number: 352

Psychometric Features of a New Methotrexate (MTX)-Specific Adherence Tool for Use in the Management of Patients with Rheumatoid Arthritis (RA): Preliminary Results from an Online Patient Community

9:00AM-11:00AM: Abstract Number: 344

Real World Clinical Trial Comparing the Patient Reported Outcomes Measurement Information System Short Forms and Profiles to CDAI Disease Classification in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 348

The Impact of Rheumatoid Arthritis-Sustained Remission on Patient´s Reported Outcomes Differs Accordingly to Each Particular Outcome

9:00AM-11:00AM: Abstract Number: 345

The Patient Experience of Musculoskeletal Imaging Tests for Investigation of Inflammatory Arthritis: A Mixed Methods Study

9:00AM-11:00AM: Abstract Number: 341

Understanding Perceptions and Experience of Gout through Linguistic Analysis of Online Search Activities

9:00AM-11:00AM: Abstract Number: 346

What Are We Measuring? Influence of Contextual Factors on RAPID3 Scores in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 343

What Is the Impact of Functional Medicine on Patient Reported Outcomes in Inflammatory Arthritis?

9:00AM-11:00AM: Abstract Number: 363

Work Productivity Benefit in Patients with Rheumatoid Arthritis Initiating Etanercept in the United States

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].